✦ LIBER ✦

Comorbidities, Not Age, Impact Outcomes in Autologous Stem Cell Transplant for Relapsed Non-Hodgkin Lymphoma

✍ Scribed by Tanya M. Wildes; Kristan M. Augustin; Diane Sempek; Qin Jean Zhang; Ravi Vij; John F. Dipersio; Steven M. Devine

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outcomes of autologous or allogeneic ste

✍ Reddy, Nishitha M.; Oluwole, Olalekan; Greer, John P.; Engelhardt, Brian G.; Jag 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 335 KB

Autologous hematopoietic stem cell trans

✍ Buadi, F K; Micallef, I N; Ansell, S M; Porrata, L F; Dispenzieri, A; Elliot, M 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 155 KB

Rituximab: Enhancing outcome of autologo

✍ Christian Gisselbrecht; Nicolas Mounier 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 167 KB

B-cell purging in autologous stem-cell t

✍ Eric Jacobsen; Arnold Freedman 📂 Article 📅 2004 🏛 The Lancet 🌐 English ⚖ 381 KB

Pre-Transplant Clonal Cytogenetic Abnorm

✍ A.M. Rojas; S. De Vos; L. Pinter-Brown; R. Paquette; S. Schiller; M.C. Territo 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Allogeneic stem cell transplantation in

✍ Ji-Won Kim; Byung-Su Kim; Soo-Mee Bang; Inho Kim; Dong Hwan Kim; Won Seog Kim; D 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 197 KB